7Sima AA.New insights into the metabolic and molecular basis for diabetic neuropathy.Cell Mol Life Sci,2003,60:1-20.
8Ziegler D,Siekierka KE,Meyer B,et al.Validation of a novel screening device(NeuroQuick) for quantitative assessment of small nerve fiber dysfunction as an early feature of diabetic polyneuropathy.Diabetes Care,2005,28:1169-1174.
9Bouhon AJ,Vinik AI,Arezzo JC,et al.Diabetic neuropathies:a statement by the American Diabetes Association.Diabetes Care,2005,8:956-962.
10Zin CS,Nissen LM,Smith MT,et al.An update on the pharmacological management of post-herpetic neuralgia and painful diabetic neuropathy.CNS Drugs,2008,22:417-442.
2Okada K,Tanaka H,Temporin K,et al.Methylcobalamin increases Erk1/2 and Akt activities through the methylation cycle and promotes nerve regeneration in a rat sciatic nerve injury model[J].Exp Neurol,2010,222(2):191-203.
4Brownlee M.The pathobiology of diabetic complications:unifying mechanism[J].Diabetes,2005,54(6):1615.
5Olaleye D,Perkins BA,Bril V.Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic[J].Diab Res Clin Pract,2001,54(2):115-128.
